Research Links Increasing ADHD Drug Dosages to Increased Risk of Psychosis

Recent studies have identified a troubling link between higher doses of stimulant medications used to treat attention deficit hyperactivity disorder (ADHD) and an increased risk of psychosis among users. This side effect, while rare, underscores the importance of carefully monitoring drug dosages.

Julianna McLeod, a 26-year-old resident of Ontario, Canada, had her first psychotic episode after restarting her ADHD medication, Vyvanse, after giving birth. Already familiar with the drug, McLeod had difficulty maintaining a consistent dosing schedule, which led to accidental overdoses above the prescribed limit.

The findings shed light on the critical need to adhere to prescribed dosages, especially in medications like Vyvanse and Adderall. These stimulants, while effective for managing ADHD, pose serious risks if taken improperly.

This research highlights a crucial aspect of ADHD treatment: the balance between therapeutic benefits and potential psychiatric risks. It serves as a reminder to both healthcare providers and patients of the importance of meticulously managing drug regimens to avoid adverse effects.